1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Global Statin Market 2015-2019

Global Statin Market 2015-2019

  • July 2015
  • -
  • Infiniti Research Limited
  • -
  • 81 pages

Summary

Table of Contents

About Statin
Statin is a structural analog of HMG-CoA enzyme and is effective in reducing LDL. It shows its pharmaceutical action by inhibiting the key enzyme involved in cholesterol synthesis, which is called HMG-CoA reductase. Therefore, statin is referred to HMG-CoA reductase inhibitors. Statin has been associated with a beneficial effect on cardiovascular morbidity and mortality. It has significant anti-inflammatory and plaque-stabilizing effects. Its other effects include decreased oxidative stress and vascular inflammation with increased atherosclerotic lesions. Some of the currently available statins are atorvastatin, lovastatin, rosuvastatin, and simvastatin.
Technavio's analysts forecast the global statin market to decline at a CAGR of 7.50% over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the global statin market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of statins used for the management of lipid abnormalities and lipid-associated comorbidities such as stroke and coronary heart disease. This report provides a discussion of the market in the following three regions: Americas, APAC, and EMEA.
Technavio's report, Global Statin Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
o Americas
o APAC
o EMEA
Key Vendors
o AstraZeneca
o Merck
o Novartis
o PfizerOther Prominent Vendors
o Amgen
o Aurobindo Pharma
o Abbvie
o Abbott
o Biocon
o BC World Pharm
o Cipla
o Concord Biotech
o CKD Bio
o CJ HealthCare Corporation
o Cerenis Therapeutics
o GlaxoSmithKline
o HanAll BioPharma
o JX Pharmaceuticals
o Kowa
o Lupin
o Livzon
o Mylan
o Merz Pharmaceuticals
o SUN Pharma
o Teva
o Torrent Pharmaceuticals
o Zydus Cadila
Market Driver
o Rising Number of High Cholesterol Cases
o For a full, detailed list, view our report
Market Challenge
o Lack of Novel Molecules in Statins Category
o For a full, detailed list, view our report
Market Trend
o Switch from Statins to Non-statins
o For a full, detailed list, view our report
Key Questions Answered in this Report
o What will the market size be in 2019 and what will the growth rate be?
o What are the key market trends?
o What is driving this market?
o What are the challenges to market growth?
o Who are the key vendors in this market space?
o What are the market opportunities and threats faced by the key vendors?
o What are the strengths and weaknesses of the key vendors?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.